Shanghai ZJ Bio-Tech Co., Ltd (SHA:688317)

China · Delayed Price · Currency is CNY

17.65

-0.06 (-0.34%)

Aug 14, 2026, 3:00 PM CST

Shanghai ZJ Bio-Tech Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	118.1	124.82	178.65	274.33	2,326	2,019
Revenue Growth	-25.98%	-30.13%	-34.88%	-88.21%	15.23%	-1.62%
Gross Profit	87.67	90.85	-37.42	-7.8	1,196	1,256
Operating Income	-87.13	-91.19	-259.4	-261.08	733.81	869.79
Net Income	-43.79	-34.3	-127.46	-136.86	760.27	758.52
Earnings Per Share	-0.25	-0.19	-0.67	-0.71	3.93	3.98
EPS Growth	-	-	-	-	-1.26%	-37.62%

Revenue by Geography

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
China	120.11
Overseas	4.7
Total	124.82

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	2,826	2,901	2,783	2,769	3,148	2,936
Total Debt	286.99	298.97	4.93	7.45	8.63	-
Net Cash (Debt)	2,539	2,602	2,778	2,762	3,139	2,936
Net Cash Growth	-5.53%	-6.36%	0.60%	-12.01%	6.92%	143.70%
Net Cash Per Share	14.68	14.41	14.60	14.33	16.23	15.40

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	61.19	66.85	77.59	-81.88	584.97	641.94
Capital Expenditures	-21.97	-1.99	-19.49	-81.15	-74.56	-498.06
Free Cash Flow	39.22	64.86	58.1	-163.03	510.41	143.88
Free Cash Flow Growth	-28.04%	11.63%	-	-	254.76%	-86.52%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	74.23%	72.79%	-20.95%	-2.84%	51.40%	62.23%
Operating Margin	-73.77%	-73.06%	-145.20%	-95.17%	31.55%	43.08%
Pretax Margin	-42.84%	-33.74%	-84.28%	-57.10%	38.75%	44.40%
Profit Margin	-37.08%	-27.48%	-71.35%	-49.89%	32.68%	37.57%
FCF Margin	33.21%	51.96%	32.52%	-59.43%	21.94%	7.13%

Dividends

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	0.110	-	1.200	1.365
Dividend Per Share Growth	-	-	-12.09%	-14.69%
Dividend Yield	0.68%	-	3.79%	2.88%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	8.44	13.26
P/FCF Ratio	78.65	55.21	53.09	-	12.57	69.88
PS Ratio	26.12	28.69	17.27	14.70	2.76	4.98